Lyra Therapeutics Inc (NASDAQ: LYRA) is 167.25% higher on its value in year-to-date trading and has touched a low of $3.81 and a high of $37.50 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The LYRA stock was last observed hovering at around $20.25 in the last trading session, with the day’s gains setting it 7.33%.
Currently trading at $27.58, the stock is 303.08% and 351.89% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.08 million and changing 36.20% at the moment leaves the stock 177.25% off its SMA200. LYRA registered 66.34% gain for a year compared to 6-month loss of 190.32%. The firm has a 50-day simple moving average (SMA 50) of $5.7276 and a 200-day simple moving average (SMA200) of $9.88365.
The stock witnessed a 409.33% gain in the last 1 month and extending the period to 3 months gives it a 203.08%, and is 528.25% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 64.93% over the week and 32.68% over the month.
Lyra Therapeutics Inc (LYRA) has around 30 employees, a market worth around $36.56M and $1.19M in sales. Profit margin for the company is -6711.39%. Distance from 52-week low is 623.87% and -26.45% from its 52-week high. The company has generated returns on investments over the last 12 months (-241.11%).
The EPS is expected to grow by 66.44% this year.
Lyra Therapeutics Inc (LYRA) Top Institutional Holders
78.0 institutions hold shares in Lyra Therapeutics Inc (LYRA), with institutional investors hold 49.05% of the company’s shares. The shares outstanding are 1.32M, and float is at 1.12M with Short Float at 4.83%. Institutions hold 48.65% of the Float.
The top institutional shareholder in the company is PERCEPTIVE ADVISORS LLC with over 12.76 million shares valued at $3.53 million. The investor’s holdings represent 19.4892% of the LYRA Shares outstanding. As of 2024-06-30, the second largest holder is CITADEL ADVISORS LLC with 4.77 million shares valued at $$1.32 million to account for 7.2912 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 2.83 million shares representing 4.3232% and valued at over $0.78 million, while SAMSARA BIOCAPITAL, LLC holds 4.2473 of the shares totaling 2.78 million with a market value of $0.77 million.
Lyra Therapeutics Inc (LYRA) Insider Activity
#####
